Area of research
Cancer Research · Oncology
Research interest
Research interests include Medicine, Docetaxel, Carboplatin, Epirubicin, Regimen, and Oncology.
Neoadjuvant docetaxel plus carboplatin vs epirubicin plus cyclophosphamide followed by docetaxel in <scp>triple‐negative</scp>, <scp>early‐stage</scp> breast cancer (<scp>NeoCART</scp>): Results from a multicenter, randomized controlled, <scp>open‐label</scp> phase <scp>II</scp> trial
Comparison of Overall Survival Between Invasive Lobular Breast Carcinoma and Invasive Ductal Breast Carcinoma: A Propensity Score Matching Study Based on SEER Database